This out-of-favor drug maker is taking the steps needed to ensure it not only survives but thrives over the long term.

Pfizer beat Q3 estimates with 87 cents EPS, raised 2025 profit guidance, as Eliquis and Vyndaqel growth offset declining COVID product sales.

Oct 9 (Reuters) - Pfizer Inc (PFE.N), opens new tab said on Friday its cancer drug Ibrance did not meet the main goal in a late-stage trial in patients with a type of breast cancer, the latest setback ...

Pfizer (PFE), one of the world’s oldest and most respected pharmaceutical companies, is currently facing significant stock ...

President Donald Trump today, Sept. 30, announced TrumpRX, a new website for Americans to buy drugs, while he touted lower prices across Pfizer drugs, according to the Wall Street Journal. Trump ...